Transdermal Drug Patches to 2024

Wednesday, December 6, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 5, 2017 /PRNewswire/ -- Transdermal drug patches to 2024 analyzes products, markets and commercialization

factors for drug patches. The report examines the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver.

Read the full report: https://www.reportlinker.com/p01941669

Advances

in synthetic materials and patch design have led to patches that are more aesthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2024.

What You Will Learn• What are the current transdermal drug patch markets and products, and what is the market potential for existing and probable future products?• What is the impact of patch designs, technologies and patch development issues on commercialization?• Who are the leading patch manufacturers and third-party transdermal supply chain companies?• What is the current product and competitive landscape, and what are the details of the numerous products across the various patch product categories and markets?• What is the size of the market now, and how will it change in the next seven years to 2024?• Who are the transdermal drug patch product providers, and what are their product development activity, and strategies?• What is the market impact of economic, technology, and regulatory factors?

Read the full report: https://www.reportlinker.com/p01941669

About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

 

View original content:http://www.prnewswire.com/news-releases/transdermal-drug-patches-to-2024-300567462.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store